Alternative Room Disinfection Modalities –Pros and Cons - Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections - page 201

2. Bhalla A, Aron DC, Donskey CJ (2007) Staphylococcus aureus intestinal colonization is
associated with increased frequency of S. aureus on skin of hospitalized patients. BMC Infect
Dis 7:105, pp 1-7
3. Oie S, Suenaga S, Sawa A, Kamiya A (2007) Association between isolation sites of
methicillin-resistant Staphylococcus aureus (MRSA) in patients with MRSA-positive body
sites and MRSA contamination in their surrounding environmental surfaces. Jpn J Infect Dis
60(6):367-369
4. Zilberberg MD, Tillotson GS, McDonald LC (2010) Clostridium difficile infections among
hospitalized children, United States, 1997-2006. Emerg Infect Dis 16(4):604-609
5. Wilcox MH et al (2003) Comparison of the effect of detergent versus hypochlorite cleaning
on environmental contamination and incidence of Clostridium difficile infection. J Hosp
Infect 54(2):109-114
6. Denton M et al (2004) Role of environmental cleaning in controlling an outbreak of
Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect 56(2):106-110
7. Baran G et al (2008) Risk factors for nosocomial imipenem-resistant Acinetobacter

baumannii infections. Int J Infect Dis 12(1):16-21
8. APIC (2010) Guide to the elimination of multidrug-resistant Acinetobacter baumannii
transmission in healthcare settings, APIC Headquarters, Washington, DC, pp 1-58
9. Wikswo ME, Hall AJ (2012) Outbreaks of acute gastroenteritis transmitted by person-
to-person contact-United States, 2009-2010. MMWR Surveill Summ 61(9):1-12
10. CDC (2009) Guidance for control of infections with carbapenem-resistant or carbapenemase-
producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep
58(10):256-260
11. Gupta N, Limbago BM, Patel JB, Kallen AJ (2011) Carbapenem-resistant Enterobac-
teriaceae: epidemiology and prevention. Clin Infect Dis 53(1):60-67
12. Correa L et al (2013) A hospital-based matched case-control study to identify clinical
outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infec-
tion. BMC Infect Dis 13:80. doi: 10.1186/1471-2334-13-80
13. Klevens RM et al (2007) Estimating health care-associated infections and deaths in
U.S. hospitals, 2002. Public Health Rep 122(2):160-166
14. Scott RD (2009) The direct medical costs of healthcare-associated infections in

U.S. Hospitals and the benefits of prevention, CS200891-A. CDC, Atlanta, pp 1-13
15. De Angelis G, Murthy A, Beyersmann J, Harbarth S (2010) Estimating the impact of
healthcare-associated infections on length of stay and costs Excess costs of healthcare-
associated infection. Clin Microbiol Infect 16(12):1729-1735
16. Graves N et al (2010) Estimating the cost of health care G ¸¨ associated infections: mind your
p's and q's. Clin Infect Dis 50(7):1017-1021
17. Neidell MJ et al (2012) Costs of healthcare- and community-associated infections
with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis
55(6):807-815
18. Stone PW et al (2010) CMS changes in reimbursement for HAIs: setting a research agenda.
Med Care 48(5):433-439
19. Stewart DB, Hollenbeak CS (2011) Clostridium difficile colitis: factors associated with
outcome and assessment of mortality at a national level. J Gastrointest Surg 15(9):1548-1555
20. Duckro AN, Blom DW, Lyle EA, Weinstein RA, Hayden MK (2005) Transfer of vancomycin-
resistant enterococci via health care worker hands. Arch Intern Med 165(3):302-307
21. de Lassence A et al (2006) Control and outcome of a large outbreak of colonization and
infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit.
Clin Infect Dis 42(2):170-178
22. CDC (2003) Guidelines for environmental infection control in health-care facilities: recom-
mendations of the CDC and the Healthcare Infection Control Practices Advisory Committee
(HICPAC). MMWR 52(RR-10):1-48
23. Boyce JM, Potter-Bynoe G, Chenevert C, King T (1997) Environmental contamination due to
methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect
Control Hosp Epidemiol 18(9):622-627